USING COMPUTERIZED INDIVIDUAL MEDICATION DATA TO DETECT DRUG EFFECTS ON CLINICAL LABORATORY TESTS

被引:14
作者
GRONROOS, P
IRJALA, K
HEISKANEN, J
TORNIAINEN, K
FORSSTROM, JJ
机构
[1] UNIV TURKU,CENT HOSP,DEPT PHARM,SF-20520 TURKU,FINLAND
[2] UNIV TURKU,CENT HOSP,DEPT MED,SF-20520 TURKU,FINLAND
关键词
ADVERSE DRUG REACTION; DRUG INTERACTION; HOSPITAL DATA; HOSPITAL PHARMACY; HOSPITAL INFORMATION SYSTEM; MEDICATION DATABASE;
D O I
10.3109/00365519509088448
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In clinical practice, thousands of drugs are used daily. Clinicians know the therapeutic effects of drugs but other minor drug effects are often ignored either because of inadequate knowledge of these effects or simply because of the limited memory capacity of a human being. This problem can be solved by using a computerized information system, which includes medication data of individual patients as well as information about non-therapeutic drug-effects. One of these non-therapeutic confusing drug effects is the influence of drugs on laboratory tests; a problem that should be taken into account in clinical practice and diagnostics. Other complicating drug effects include drug interactions and patient related adverse drug reactions. In a computerized information system, it is possible to build decision support modules that automatically give alarms or alerts of important drug effects other than therapeutic effects. If these warnings concern laboratory tests they are checked by a laboratory physician and only those with clinical significance are sent to clinicians. Warnings of drug interactions and adverse drug reactions are immediately evaluated by the physician responsible for the treatment. By means of the computerized information system, it is also possible to get better information of current medication practice which in turn gives better chances to agree on common guidelines and enables better quality assurance.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 12 条
[1]  
Classen D C, 1992, Hosp Pharm, V27, P776
[2]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851
[3]   METHODS USED BY PHARMACY DEPARTMENTS TO IDENTIFY DRUG-INTERACTIONS [J].
ELANJIAN, S ;
GORA, ML ;
SYMES, LR .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (12) :2546-2549
[4]   IMPROVING EMPIRIC ANTIBIOTIC SELECTION USING COMPUTER DECISION-SUPPORT [J].
EVANS, RS ;
CLASSEN, DC ;
PESTOTNIK, SL ;
LUNDSGAARDE, HP ;
BURKE, JP .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (08) :878-884
[5]   PREVENTING ADVERSE DRUG EVENTS IN HOSPITALIZED-PATIENTS [J].
EVANS, RS ;
PESTOTNIK, SL ;
CLASSEN, DC ;
HORN, SD ;
BASS, SB ;
BURKE, JP .
ANNALS OF PHARMACOTHERAPY, 1994, 28 (04) :523-527
[6]  
FRIEDMAN RB, 1989, EFFECTS DRUGS CLIN L
[7]  
GARDNER RM, 1992, J AM HLTH INFO MANAG, V3, P68
[8]  
Linnarsson Rolf, 1993, Scandinavian Journal of Primary Health Care, V11, P181, DOI 10.3109/02813439308994827
[9]   PERSONAL COMPUTER-BASED EXPERT-SYSTEM FOR QUALITY ASSURANCE OF ANTIMICROBIAL THERAPY [J].
MORRELL, R ;
WASILAUSKAS, B ;
WINSLOW, R .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (10) :2067-2073
[10]  
Pryor T A, 1983, J Med Syst, V7, P87, DOI 10.1007/BF00995116